Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lamberts Natural Vitamin E 250unit capsules
0906050P0CTAAAH
|
Lamberts Vitamin E | Vitamin E | Nutrition and Blood | No data available |
|
Lamberts Natural Vitamin E 400unit capsules
0906050P0CTABAF
|
Lamberts Vitamin E | Vitamin E | Nutrition and Blood | No data available |
|
Lamberts Omega 369 1200mg capsules
091200000BFSTA0
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Lamberts Selenium 200microgram tablets
090504700BBFPBC
|
Proprietary compound preparation BNF 0905047 | Other selenium preparations | Nutrition and Blood | No data available |
|
Lamberts Taurine 500mg capsules
0911010T0BCAAAA
|
Lamberts Taurine | Taurine | Nutrition and Blood | No data available |
|
Lamberts Vegan Glucosamine hydrochloride 660mg tablets
1001050A0CBABAR
|
Lambert's (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Lamberts Vegetarian Glucosamine hydrochloride 750mg tablets
1001050A0CBAAAB
|
Lambert's (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Lamberts Vitamin D3 1,000unit tablets
0906040G0BJAABG
|
Lamberts Colecalciferol | Colecalciferol | Nutrition and Blood | No data available |
|
Lamberts Vitamin D3 280unit chewable tablets
0906040G0BJACCZ
|
Lamberts Colecalciferol | Colecalciferol | Nutrition and Blood | No data available |
|
Lamberts Zinc 15mg tablets
090504100BBBQBC
|
Proprietary compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | No data available |
|
Lamberts Zinc 50mg capsules
090504100BBBRBB
|
Proprietary compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | No data available |
|
Lamivudine 25mg/5ml oral solution
0503010Q0AAACAC
|
Lamivudine | Lamivudine | Infections | No data available |
|
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets
0503010AVAAAAAA
|
Lamivudine/tenofovir disoproxil | Lamivudine/tenofovir disoproxil | Infections | No data available |
|
Lamotrigine 1.5mg/5ml oral liquid
0408010H0AABMBM
|
Lamotrigine | Lamotrigine | Central Nervous System | No data available |
|
Lamotrigine 1.7mg/5ml oral liquid
0408010H0AABSBS
|
Lamotrigine | Lamotrigine | Central Nervous System | No data available |
|
Lamotrigine 10mg/5ml oral suspension
0408010H0AABUBU
|
Lamotrigine | Lamotrigine | Central Nervous System | No data available |
|
Lamotrigine 15mg/5ml oral liquid
0408010H0AAAZAZ
|
Lamotrigine | Lamotrigine | Central Nervous System | No data available |
|
Lamotrigine 200mg dispersible tablets sugar free
0408010H0AABQBQ
|
Lamotrigine | Lamotrigine | Central Nervous System | No data available |
|
Lamotrigine 200mg/5ml oral liquid
0408010H0AABGBG
|
Lamotrigine | Lamotrigine | Central Nervous System | No data available |
|
Lamotrigine 20mg/5ml oral suspension
0408010H0AABNBN
|
Lamotrigine | Lamotrigine | Central Nervous System | No data available |
|
Lamotrigine 37.5mg/5ml oral liquid
0408010H0AAA4A4
|
Lamotrigine | Lamotrigine | Central Nervous System | No data available |
|
Lamotrigine 5.5mg/5ml oral liquid
0408010H0AAA5A5
|
Lamotrigine | Lamotrigine | Central Nervous System | No data available |
|
Lamotrigine 50mg dispersible tablets sugar free
0408010H0AABPBP
|
Lamotrigine | Lamotrigine | Central Nervous System | No data available |
|
Lamotrigine 5mg/5ml oral liquid
0408010H0AABEBE
|
Lamotrigine | Lamotrigine | Central Nervous System | No data available |
|
Lamotrigine 60mg/5ml oral liquid
0408010H0AABTBT
|
Lamotrigine | Lamotrigine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.